Postmenopausal Cardiovascular Disease Biomarkers Discovered
Quantifying Urinary Biomarkers of Kidney Damage Using Multiplex Panels
Advancing Cancer Drug Development Using Biomarkers
Developing and Validating Imaging Biomarkers in Preclinical Drug Development
Ocular Disease Identifying Biomarkers in Ocular Fluid
Genomics-Based Gene Expression Signature Biomarkers in Oncology and Toxicology Enable in Drug Discovery and Translational Medicine
Role of Inflammation in Vascular Disease Shown by Biomarker Ratifies Ethnic Group Disease Progressions (USA)
Kidney Damage Biomarkers to Help in Speeding Drug Development
Parkinson's Disease and Need for Biomarkers
Goal of Effective and Personalized Cancer Medicine to be Realized by Biomarkers
Acute Coronary Syndrome and Diagnostic Biomarkers
Pharmacodynamic Biomarkers for Molecular Cancer Therapeutics
A Metabonomic Approach to Identify Human Urinary Phenylacetylglutamine as an Innovative Marker of Interstitial Cystitis
Serum Biomarker for Autistic Spectrum Disorder
Prognostic Biomarker in Human Bladder Cancer
Breast Cancer Biomarker Discovery Using New Method
1.6 Major Global Players
ACE BioSciences A/S
AVIVA Biosciences Corporation
Beckman Coulter, Inc.
Becton, Dickinson and Company
BG Medicine, Inc.
Biacore International AB
Biomarker Pharmaceuticals, Inc.
Bristol-Myers Squibb Company
Charles River Laboratories International, Inc.
Eli Lilly and Compan
Copyright©2010 PR Newswire.
All rights reserved